Back to top
more

Zoetis Inc. (ZTS)

(Delayed Data from NYSE)

$92.27 USD

92.27
1,468,298

+0.65 (0.71%)

Updated Nov 16, 2018 03:58 PM ET

Add to portfolio

2-Buy   2      

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1
2
3
4
5
S&P
Strong Buy
Buy
Hold
Sell
Strong Sell
500
25.32%
18.25%
9.79%
5.22%
2.14%
10.57%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

C Value | B Growth | D Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Can Zoetis (ZTS) Stock Continue to Grow Earnings?

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Zoetis (ZTS).

ZTS

Zacks Equity Research

Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View

Zoetis (ZTS) beats both earnings and sales estimates in the third quarter of 2018. The company also updates its 2018 outlook.

MRK LLY BMY ZTS

Zacks Equity Research

Zoetis (ZTS) Tops Q3 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 7.79% and 1.35%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

ZTS

Zacks Equity Research

Zoetis (ZTS) Q3 Earnings & Revenues Surpass Estimates

Zoetis beats earnings and sales estimates in the third quarter of 2018.

ZTS

Zacks Equity Research

Should You Buy Zoetis (ZTS) Ahead of Earnings?

Zoetis (ZTS) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

ZTS

Zacks Equity Research

Zoetis (ZTS) Q3 Earnings Preview: What's in the Cards?

Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZTS

Zacks Equity Research

Is a Beat in Store for Zoetis (ZTS) This Earnings Season?

Zoetis' (ZTS) diversified product portfolio, global footprint and productive R&D should help drive both top-and bottom-line growth in the third quarter of 2018.

AMAG ALNY AMGN ZTS

Zacks Equity Research

Why the Earnings Surprise Streak Could Continue for Zoetis (ZTS)

Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ZTS

Mark Vickery

Top Research Reports for Pfizer, Caterpillar & Charter Communications

Today's Research Daily features new research reports on 12 major stocks, including Pfizer (PFE), Caterpillar (CAT) and Charter Communications (CHTR).

ZTS SHW PXD PFE CHTR CAT

Zacks Equity Research

JAZZ or ZTS: Which Is the Better Value Stock Right Now?

JAZZ vs. ZTS: Which Stock Is the Better Value Option?

JAZZ ZTS

Zacks Equity Research

The Zacks Analyst Blog Highlights: Champions Oncology, CytoDyn, Infinity Pharmaceuticals, Nektar Therapeutics and Zoetis

The Zacks Analyst Blog Highlights: Champions Oncology, CytoDyn, Infinity Pharmaceuticals, Nektar Therapeutics and Zoetis

NKTR CSBR CYDY INFI ZTS

Zacks Equity Research

5 Best Biotech Stocks to Buy In October

Successful drug trials at several biopharmas and FDA approvals make biotech companies a strong investment choice in October

AGN VKTX ACAD AMRN SRPT ALXN GILD INFI CSBR CYDY NKTR ZTS MDGL

Zacks Equity Research

Eli Lilly Prices Animal Health Unit IPO at $24 Per Share

Lilly (LLY) prices Elanco IPO at $24 per share which is above the expected range of $20-$23 per share.

LLY NVS PFE ZTS

Zacks Equity Research

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoetis

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Coca-Cola, Disney, BHP and Zoetis

DIS KO BRK.B ZTS BHP

Mark Vickery

Top Analyst Reports for Berkshire Hathaway, Coca-Cola & Disney

Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Coca-Cola (KO) and Disney (DIS).

ZTS PTR KO DIS BRK.B BHP

Zacks Equity Research

Zoetis (ZTS) Beats on Q2 Earnings & Sales, Updates '18 View

Zoetis second-quarter 2018 results exceed both earnings and sales estimates. The company completes the acquisition of Abaxis, Inc.

REGN GILD VNDA ZTS

Zacks Equity Research

Zoetis (ZTS) Q2 Earnings and Revenues Beat Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 8.45% and 2.21%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

ZTS

Zacks Equity Research

Drug Stock Q2 Earnings Releases on Aug 2: ZTS, REGN & More

Let's see how these pharma/biotech stocks are poised ahead of their scheduled results on Aug 2.

SNY PFE REGN BMRN ALNY RARE ZTS

Zacks Equity Research

CTLT vs. ZTS: Which Stock Is the Better Value Option?

CTLT vs. ZTS: Which Stock Is the Better Value Option?

CTLT ZTS

Zacks Equity Research

The Zacks Analyst Blog Highlights: PayPal, ConocoPhillips, T-Mobile, Zoetis and PACCAR

The Zacks Analyst Blog Highlights: PayPal, ConocoPhillips, T-Mobile, Zoetis and PACCAR

PYPL PCAR ZTS COP TMUS

Zacks Equity Research

Top Stock Reports for PayPal, ConocoPhillips & T-Mobile

Today's Research Daily features new research reports on 16 major stocks, including PayPal (PYPL), ConocoPhillips (COP) and T-Mobile (TMUS).

ZTS TMUS PYPL PCAR ECL COP

Zacks Equity Research

Abaxis (ABAX) and Zoetis Merger Deal Crosses HRS Hurdle

With the adoption of Abaxis' (ABAX) point-of-care diagnostic instruments post acquisition, the combined entity's veterinary diagnostics category should grow faster than the animal health industry.

ABAX GHDX ZTS ALGN

Zacks Equity Research

Zoetis (ZTS) Tides Over HSR Hurdle for Abaxis Acquisition

Zoetis' (ZTS) waiting period under the HSR Act ends. It is related to its proposed merger with Abaxis for a purchase consideration of roughly $2 billion in aggregate.

ABAX GHDX TARO ZTS

Zacks Equity Research

CTLT vs. ZTS: Which Stock Should Value Investors Buy Now?

CTLT vs. ZTS: Which Stock Is the Better Value Option?

CTLT ZTS

Zacks Equity Research

Why Is Zoetis (ZTS) Up 5.7% Since Its Last Earnings Report?

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ZTS